Title: 
Official Title: 
Number of Sections: 1
Source: versions - Introduced
Media Type: text/html

================================================================================

Section 1:
Senate File 202 - Introduced SENATE FILE 202 BY BISIGNANO A BILL FOR An Act relating to ensuring the provision of accessible 1 prescription-related measures for persons who are 2 blind, have a visual impairment, or otherwise have print 3 disabilities. 4 BE IT ENACTED BY THE GENERAL ASSEMBLY OF THE STATE OF IOWA: 5 TLSB 2046XS (1) 91 lh/ko S.F. 202 Section 1. NEW SECTION . 155A.49 Accessible 1 prescription-related measures for persons who are blind, 2 visually impaired, or otherwise have print disabilities ââ rules. 3 1. The board shall adopt rules pursuant to chapter 17A 4 to ensure that no later than October 31, 2025, a person who 5 is blind, has a visual impairment, or otherwise has a print 6 disability has appropriate access to prescription drug labels, 7 bag tags, and medical guides. The accessibility measures shall 8 meet all of the following requirements: 9 a. Be provided at no additional cost to such persons. 10 b. Provide information in a format that is fully accessible 11 to a person who is blind, has a visual impairment, or otherwise 12 has a print disability. 13 c. Provide information to a person who is blind, has a 14 visual impairment, or otherwise has a print disability within 15 a time frame comparable to the time frame within which the 16 information is provided to a person who is not blind, does not 17 have a visual impairment, or does not otherwise have a print 18 disability. 19 2. In adopting rules under this section, the board shall 20 solicit input from persons who are blind, have a visual 21 impairment, or otherwise have a print disability. 22 3. The rules adopted under this section shall meet all of 23 the following requirements: 24 a. Comply with the guidelines and recommendations in the 25 United States government accountability office report published 26 in December 2016, entitled âPrescription Drug Labels: Actions 27 Needed to Increase Awareness of Best Practices for Accessible 28 Labels for Individuals Who are Blind or Visually Impairedâ. 29 b. Include a method for providing notice to the public 30 that accessible prescription drug labels, bag tags, and 31 medical guides are available, including notice regarding the 32 availability of the prescription drug labels, bag tags, and 33 medical guides in audio format. 34 4. The board shall submit a report to the governor and the 35 -1- LSB 2046XS (1) 91 lh/ko 1/ 3 S.F. 202 general assembly by January 1, 2026, which includes information 1 regarding progress in the implementation of the rules, 2 recommendations regarding additional measures for improving 3 accessibility, and projected costs of implementing enhanced 4 dispensing fees to defray the costs of providing accessible 5 prescription drug labels, bag tags, and medical guides to 6 persons who are blind, have a visual impairment, or otherwise 7 have a print disability. 8 EXPLANATION 9 The inclusion of this explanation does not constitute agreement with 10 the explanationâs substance by the members of the general assembly. 11 This bill requires the board of pharmacy to adopt 12 administrative rules no later than October 31, 2025, to 13 ensure that a person who is blind, has a visual impairment, 14 or otherwise has a print disability has appropriate access to 15 prescription drug labels, bag tags, and medical guides. The 16 accessibility measures shall be provided at no additional cost 17 to such person, provide information in a format that is fully 18 accessible to a person who is blind, has a visual impairment, 19 or otherwise has a print disability, and provide information to 20 a person who is blind, has a visual impairment, or otherwise 21 has a print disability within a time frame comparable to the 22 time frame within which the information is provided to a 23 person who is not blind, does not have a visual impairment, or 24 otherwise does not have a print disability. 25 The board is required to solicit input in developing the 26 rules from persons who are blind, have a visual impairment, 27 or otherwise have a print disability. The rules shall comply 28 with the guidelines and recommendations in the United States 29 government accountability office report published in December 30 2016, entitled âPrescription Drug Labels: Actions Needed to 31 Increase Awareness of Best Practices for Accessible Labels for 32 Individuals Who are Blind or Visually Impairedâ, and shall 33 include a method for providing notice to the public that 34 accessible prescription drug labels, bag tags, and medical 35 -2- LSB 2046XS (1) 91 lh/ko 2/ 3 S.F. 202 guides are available. 1 The board shall submit a report to the governor and the 2 general assembly by January 1, 2026, which includes information 3 regarding progress in the implementation of the rules, 4 recommendations regarding additional measures for improving 5 accessibility, and projected costs of implementing enhanced 6 dispensing fees to defray the costs of providing accessible 7 prescription drug labels, bag tags, and medical guides to 8 persons who are blind, have a visual impairment, or otherwise 9 have a print disability. 10 -3- LSB 2046XS (1) 91 lh/ko 3/ 3


================================================================================

Raw Text:
Senate File 202 - Introduced SENATE FILE 202 BY BISIGNANO A BILL FOR An Act relating to ensuring the provision of accessible 1 prescription-related measures for persons who are 2 blind, have a visual impairment, or otherwise have print 3 disabilities. 4 BE IT ENACTED BY THE GENERAL ASSEMBLY OF THE STATE OF IOWA: 5 TLSB 2046XS (1) 91 lh/ko S.F. 202 Section 1. NEW SECTION . 155A.49 Accessible 1 prescription-related measures for persons who are blind, 2 visually impaired, or otherwise have print disabilities ââ rules. 3 1. The board shall adopt rules pursuant to chapter 17A 4 to ensure that no later than October 31, 2025, a person who 5 is blind, has a visual impairment, or otherwise has a print 6 disability has appropriate access to prescription drug labels, 7 bag tags, and medical guides. The accessibility measures shall 8 meet all of the following requirements: 9 a. Be provided at no additional cost to such persons. 10 b. Provide information in a format that is fully accessible 11 to a person who is blind, has a visual impairment, or otherwise 12 has a print disability. 13 c. Provide information to a person who is blind, has a 14 visual impairment, or otherwise has a print disability within 15 a time frame comparable to the time frame within which the 16 information is provided to a person who is not blind, does not 17 have a visual impairment, or does not otherwise have a print 18 disability. 19 2. In adopting rules under this section, the board shall 20 solicit input from persons who are blind, have a visual 21 impairment, or otherwise have a print disability. 22 3. The rules adopted under this section shall meet all of 23 the following requirements: 24 a. Comply with the guidelines and recommendations in the 25 United States government accountability office report published 26 in December 2016, entitled âPrescription Drug Labels: Actions 27 Needed to Increase Awareness of Best Practices for Accessible 28 Labels for Individuals Who are Blind or Visually Impairedâ. 29 b. Include a method for providing notice to the public 30 that accessible prescription drug labels, bag tags, and 31 medical guides are available, including notice regarding the 32 availability of the prescription drug labels, bag tags, and 33 medical guides in audio format. 34 4. The board shall submit a report to the governor and the 35 -1- LSB 2046XS (1) 91 lh/ko 1/ 3 S.F. 202 general assembly by January 1, 2026, which includes information 1 regarding progress in the implementation of the rules, 2 recommendations regarding additional measures for improving 3 accessibility, and projected costs of implementing enhanced 4 dispensing fees to defray the costs of providing accessible 5 prescription drug labels, bag tags, and medical guides to 6 persons who are blind, have a visual impairment, or otherwise 7 have a print disability. 8 EXPLANATION 9 The inclusion of this explanation does not constitute agreement with 10 the explanationâs substance by the members of the general assembly. 11 This bill requires the board of pharmacy to adopt 12 administrative rules no later than October 31, 2025, to 13 ensure that a person who is blind, has a visual impairment, 14 or otherwise has a print disability has appropriate access to 15 prescription drug labels, bag tags, and medical guides. The 16 accessibility measures shall be provided at no additional cost 17 to such person, provide information in a format that is fully 18 accessible to a person who is blind, has a visual impairment, 19 or otherwise has a print disability, and provide information to 20 a person who is blind, has a visual impairment, or otherwise 21 has a print disability within a time frame comparable to the 22 time frame within which the information is provided to a 23 person who is not blind, does not have a visual impairment, or 24 otherwise does not have a print disability. 25 The board is required to solicit input in developing the 26 rules from persons who are blind, have a visual impairment, 27 or otherwise have a print disability. The rules shall comply 28 with the guidelines and recommendations in the United States 29 government accountability office report published in December 30 2016, entitled âPrescription Drug Labels: Actions Needed to 31 Increase Awareness of Best Practices for Accessible Labels for 32 Individuals Who are Blind or Visually Impairedâ, and shall 33 include a method for providing notice to the public that 34 accessible prescription drug labels, bag tags, and medical 35 -2- LSB 2046XS (1) 91 lh/ko 2/ 3 S.F. 202 guides are available. 1 The board shall submit a report to the governor and the 2 general assembly by January 1, 2026, which includes information 3 regarding progress in the implementation of the rules, 4 recommendations regarding additional measures for improving 5 accessibility, and projected costs of implementing enhanced 6 dispensing fees to defray the costs of providing accessible 7 prescription drug labels, bag tags, and medical guides to 8 persons who are blind, have a visual impairment, or otherwise 9 have a print disability. 10 -3- LSB 2046XS (1) 91 lh/ko 3/ 3